What is Abacavir-lamivudine?

Category: Prescription Drugs

Most popular types: Epzicom Kivexa

false

Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 137 51
Increase effect of another treatment 3 4
Support immune health 3 4
Fatigue 2 1
Acquired immune deficiency syndrome 1 0
Emotional tension 1 0

Show all 8 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 4
Moderate 5
Mild 10
None 38

Commonly reported side effects and conditions associated with Abacavir-lamivudine

Side effect Patients
Fatigue 5
Nausea 3
Anxious mood 2
Diarrhea 2
Lipodystrophy (lipoatrophy or loss of fatty tissue) 2
Abdominal cramps 1

Show all 20 reported side effects

Dosages

Based on patients currently taking Abacavir-lamivudine

Dosage Patients
600 mg-300 mg daily 3
300 mg daily 1

Why patients stopped taking Abacavir-lamivudine

Multiple reasons could be selected

Reason Patients
Doctor's advice 11
Other 11
Side effects too severe 9
Personal research 2
Course of treatment ended 1
Did not seem to work 1
Expense 1
See all 29 patients who've stopped taking Abacavir-lamivudine

Duration

Currently taking Abacavir-lamivudine

Duration Patients
5 - 10 years 1
10 years or more 3

Stopped taking Abacavir-lamivudine

Duration Patients
Less than 1 month 4
1 - 6 months 4
6 months - 1 year 6
1 - 2 years 5
2 - 5 years 6
5 - 10 years 3
10 years or more 1
Adherence
Adherence Evaluations
Always 48
Usually 4
Sometimes 1
Never taken as prescribed 4
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 0
A little hard to take 12
Not at all hard to take 43
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 3
$25-49 7
< $25 19
Not specified 28

What people switch to and from

Patients started taking Abacavir-lamivudine after stopping:

Treatment Patients
Emtricitabine-Tenofovir (Truvada) 4
Atazanavir (Reyataz) 1
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1

Patients stopped taking Abacavir-lamivudine and switched to:

Treatment Patients
Triumeq 4
Abacavir-lamivudine-zidovudine (Trizivir) 1
Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide (Genvoya) 1
Raltegravir (Isentress) 1
Last updated:

7 patient evaluations for Abacavir-lamivudine

Jun 23, 2014 (Started Feb 21, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily

  • 0 helpful marks

Aug 24, 2011 (Started May 06, 2011)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 600 mg-300 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Feb 13, 2009 (Started Dec 01, 2005)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg-300 mg Daily
Cost: < $25 monthly
Side effects: fatigue

  • 0 helpful marks
Last updated:
Showing 3 of 7 patient evaluations for Abacavir-lamivudine